Efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer patients with rare KRAS mutations: a real-world retrospective study.
Jiang H, Li Y, Wang Y, Zou B, Chen Y, Zhang Y, Husain H, Forest F, Qian F, Zhang L, Zhou C, Liu H, Wang D, Zhang W, Lu J, Han B.
Jiang H, et al. Among authors: wang y, wang d.
Transl Lung Cancer Res. 2024 Jul 30;13(7):1672-1684. doi: 10.21037/tlcr-24-372. Epub 2024 Jul 25.
Transl Lung Cancer Res. 2024.
PMID: 39118889
Free PMC article.